Cefkind Pharmaceuticals Private Limited
About Cefkind Pharmaceuticals Private Limited
Data last updated:
Cefkind Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 30 June 2022.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24290MH2022PTC385812.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Mohammad Sharif Abdul Rehman Siddique and Chandrajeet Baliram Yadav.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 6/B G – 4 Shantata Vikas Sra Chs. Ltd. Golibar Road Santacruz East, Mumbai, Maharashtra, India – 400055.
As per the financials filed for FY 2025, the company reported a revenue of ₹58.59 Lakh, a growth of 29% compared to the previous year. For the same year it recorded a net profit of ₹2.34 Lakh (net margin 4%) and EBITDA of ₹2.86 Lakh (EBITDA margin 4.9%).
Company details
Contact details
Cefkind Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra.
- Registered Address6/B G – 4 Shantata Vikas Sra Chs. Ltd. Golibar Road Santacruz East, Mumbai, Maharashtra, India – 400055
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Cefkind Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Cefkind Pharmaceuticals Private Limited, buy the company report.
Financials of Cefkind Pharmaceuticals Private Limited
FY 2025 filings availableCefkind Pharmaceuticals Private Limited reported revenue of ₹58.59 Lakh (up 29% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 29% in the latest year. EBITDA rose 17% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹2.86 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹2.34 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 4.9% | ||
| Net Profit Margin | 4% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Cefkind Pharmaceuticals Private Limited, buy the company report.
Board of directors of Cefkind Pharmaceuticals Private Limited
Cefkind Pharmaceuticals has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohammad Sharif Abdul Rehman Siddique | Director | 30 Jun 2022 | 4 Years 3 Months | Current |
| Chandrajeet Baliram Yadav Also directs: Swarnsurya Samanya Bhagidar LLP | Director | 30 Jun 2022 | 4 Years 3 Months | Current |
| Yogesh Kumar Dubey Also directs: Swarnsurya Samanya Bhagidar LLP, Alfred Jacob Foundation | Director | 30 Jun 2022 | 4 Years 3 Months | Current |
| Monika Chandrajeet Yadav | Director | 13 Mar 2025 | 1 Years 7 Months | Current |
Peer comparison
Cefkind Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Capskii Pharmaceuticals Private Limited | ₹58.97 Lakh (FY 2025) | -2.0% | Delhi, India | |||
| Wonder Cure Pharmaceuticals P Ltd | ₹58.75 Lakh (FY 2023) | 239.0% | Mumbai, Maharashtra, India | |||
| Syomed Pharmaceuticals Private Limited | ₹58.7 Lakh (FY 2025) | -30.0% | Haldwani, Uttarakhand, India | |||
| Cefkind Pharmaceuticals Private Limitedthis company | ₹58.59 Lakh (FY 2025) | ₹2.34 Lakh | 4% | 29.0% | Mumbai, Maharashtra, India | |
| Octette Pharmaceuticals Private Limited | ₹58.36 Lakh (FY 2025) | -1.0% | Taliparamba, Kerala, India | |||
| JDR Pharmaceuticals Private Limited | ₹58.15 Lakh (FY 2024) | 1.0% | Chennai, Tamil Nadu, India | |||
| Zavlock Pharmaceuticals Private Limited | ₹57.99 Lakh (FY 2024) | 34.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Cefkind Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Cefkind Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cefkind Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Cefkind Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Cefkind Pharmaceuticals Private Limited has 4 board changes on record since 2022: 4 appointments. The latest: Monika Chandrajeet Yadav was appointed as Director on 13 Mar 2025.
Frequently asked questions
Cefkind Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 30 June 2022 (4+ years old) and is registered under CIN U24290MH2022PTC385812.
Cefkind Pharmaceuticals has 4 current directors:
- Mohammad Sharif Abdul Rehman Siddique - Director
- Chandrajeet Baliram Yadav - Director
- Yogesh Kumar Dubey - Director
- Monika Chandrajeet Yadav - Director
The latest financial statements of Cefkind Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Cefkind Pharmaceuticals is U24290MH2022PTC385812. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cefkind Pharmaceuticals was incorporated on 30 June 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Cefkind Pharmaceuticals by revenue are Capskii Pharmaceuticals Private Limited, Wonder Cure Pharmaceuticals P Ltd, Syomed Pharmaceuticals Private Limited, Octette Pharmaceuticals Private Limited, JDR Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Monika Chandrajeet Yadav was appointed as Director on 13 Mar 2025. Chandrajeet Baliram Yadav was appointed as Director on 30 Jun 2022. Mohammad Sharif Abdul Rehman Siddique was appointed as Director on 30 Jun 2022. Cefkind Pharmaceuticals has 4 board changes on record in total.
The registered office of Cefkind Pharmaceuticals is at 6B G – 4 Shantata Vikas Sra Chs. Ltd. Golibar Road Santacruz East, Mumbai, Maharashtra, India – 400055.
Cefkind Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Cefkind Pharmaceuticals can be reached at its registered office: 6B G – 4 Shantata Vikas Sra Chs. Ltd. Golibar Road Santacruz East, Mumbai, Maharashtra, India – 400055.
Cefkind Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Mumbai.